These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22948717)

  • 1. Yes is a central mediator of cell growth in malignant mesothelioma cells.
    Sato A; Sekine M; Virgona N; Ota M; Yano T
    Oncol Rep; 2012 Nov; 28(5):1889-93. PubMed ID: 22948717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events.
    Werdich XQ; Penn JS
    Angiogenesis; 2005; 8(4):315-26. PubMed ID: 16400523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
    Indovina P; Giorgi F; Rizzo V; Khadang B; Schenone S; Di Marzo D; Forte IM; Tomei V; Mattioli E; D'Urso V; Grilli B; Botta M; Giordano A; Pentimalli F
    Oncogene; 2012 Feb; 31(7):929-38. PubMed ID: 21785466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion.
    Usami N; Sekido Y; Maeda O; Yamamoto K; Minna JD; Hasegawa Y; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
    Oncogene; 2003 Sep; 22(39):7923-30. PubMed ID: 12970740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells.
    Kuga T; Nakayama Y; Hoshino M; Higashiyama Y; Obata Y; Matsuda D; Kasahara K; Fukumoto Y; Yamaguchi N
    Arch Biochem Biophys; 2007 Oct; 466(1):116-24. PubMed ID: 17692281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Src family kinases: distinct functions of c-Src, Yes, and Fyn in the liver.
    Reinehr R; Sommerfeld A; Häussinger D
    Biomol Concepts; 2013 Apr; 4(2):129-42. PubMed ID: 25436571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.
    Sato I; Obata Y; Kasahara K; Nakayama Y; Fukumoto Y; Yamasaki T; Yokoyama KK; Saito T; Yamaguchi N
    J Cell Sci; 2009 Apr; 122(Pt 7):965-75. PubMed ID: 19258394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
    Zhang P; Greendorfer JS; Jiao J; Kelpke SC; Thompson JA
    Arch Biochem Biophys; 2006 Jun; 450(1):50-62. PubMed ID: 16631103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements.
    Sandilands E; Brunton VG; Frame MC
    J Cell Sci; 2007 Aug; 120(Pt 15):2555-64. PubMed ID: 17623777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors.
    Tamm C; Galitó SP; Annerén C
    Exp Cell Res; 2012 Feb; 318(4):336-49. PubMed ID: 22197704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells.
    Kashiwagi K; Virgona N; Harada K; Kido W; Yano Y; Ando A; Hagiwara K; Yano T
    Life Sci; 2009 May; 84(19-20):650-6. PubMed ID: 19232361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity.
    Galvagni F; Pennacchini S; Salameh A; Rocchigiani M; Neri F; Orlandini M; Petraglia F; Gotta S; Sardone GL; Matteucci G; Terstappen GC; Oliviero S
    Circ Res; 2010 Jun; 106(12):1839-48. PubMed ID: 20431062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic stretch induces reorientation of cells in a Src family kinase- and p130Cas-dependent manner.
    Niediek V; Born S; Hampe N; Kirchgessner N; Merkel R; Hoffmann B
    Eur J Cell Biol; 2012 Feb; 91(2):118-28. PubMed ID: 22178114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.
    Granot-Attas S; Elson A
    Exp Cell Res; 2004 Mar; 294(1):236-43. PubMed ID: 14980517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.
    Vehviläinen P; Koli K; Myllärniemi M; Lindholm P; Soini Y; Salmenkivi K; Kinnula VL; Keski-Oja J
    Hum Pathol; 2011 Feb; 42(2):269-78. PubMed ID: 21106222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YES, a Src family kinase, is a proximal glucose-specific activator of cell division cycle control protein 42 (Cdc42) in pancreatic islet β cells.
    Yoder SM; Dineen SL; Wang Z; Thurmond DC
    J Biol Chem; 2014 Apr; 289(16):11476-11487. PubMed ID: 24610809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
    Marchetti D; Parikh N; Sudol M; Gallick GE
    Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.